Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
The Journal of the Acoustical Society of America
|
April 1, 1986
Critical modulation frequency based on detection of AM versus FM tones
E Schorer
Thrombosis Research
|
February 15, 1997
Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody
A E Schorer
Journal of the National Medical Association
|
February 1, 1987
Behavioral efficacy of propranolol in black patients
C E Schorer
International Journal of Aging & Human Development
|
January 1, 1985
Historical essay: Kraepelin's description of Alzheimer's disease
C E Schorer
Thrombosis Research
|
November 15, 1989
Interleukin 1 enhances arterial thrombogenicity in vitro
A E Schorer, J G White
The American Journal of Medicine
|
January 1, 1991
Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients
K V Watson, A E Schorer
American Journal of Hematology
|
November 1, 1995
Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum
A E Schorer, J Singh, M L Basara
The American Journal of Physiology
|
January 1, 1990
Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells
P J Shultz, A E Schorer, L Raij
The Journal of the Acoustical Society of America
|
December 1, 1986
Decision rules in detection of simple and complex tones
S Buus, E Schorer, M Florentine, et al.
British Journal of Haematology
|
October 1, 1987
Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells
A E Schorer, C F Moldow, M E Rick
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
The Journal of the Acoustical Society of America
|
April 1, 1986
Critical modulation frequency based on detection of AM versus FM tones
E Schorer
Thrombosis Research
|
February 15, 1997
Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody
A E Schorer
Journal of the National Medical Association
|
February 1, 1987
Behavioral efficacy of propranolol in black patients
C E Schorer
International Journal of Aging & Human Development
|
January 1, 1985
Historical essay: Kraepelin's description of Alzheimer's disease
C E Schorer
Thrombosis Research
|
November 15, 1989
Interleukin 1 enhances arterial thrombogenicity in vitro
A E Schorer, J G White
The American Journal of Medicine
|
January 1, 1991
Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients
K V Watson, A E Schorer
American Journal of Hematology
|
November 1, 1995
Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum
A E Schorer, J Singh, M L Basara
The American Journal of Physiology
|
January 1, 1990
Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells
P J Shultz, A E Schorer, L Raij
The Journal of the Acoustical Society of America
|
December 1, 1986
Decision rules in detection of simple and complex tones
S Buus, E Schorer, M Florentine, et al.
British Journal of Haematology
|
October 1, 1987
Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells
A E Schorer, C F Moldow, M E Rick
Page
of 3